UTP14A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.56590000147617E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.82600000009359E-07 |
Normal-vs-Stage2 |
9.464800E-03 |
Normal-vs-Stage3 |
5.603900E-04 |
Normal-vs-Stage4 |
2.33439999999252E-05 |
Stage1-vs-Stage2 |
2.116400E-01 |
Stage1-vs-Stage3 |
5.543600E-01 |
Stage1-vs-Stage4 |
2.241200E-01 |
Stage2-vs-Stage3 |
5.313400E-01 |
Stage2-vs-Stage4 |
5.611800E-02 |
Stage3-vs-Stage4 |
1.351040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.68159999761153E-08 |
Normal-vs-AfricanAmerican |
1.330190E-01 |
Normal-vs-Asian |
1.334400E-01 |
Caucasian-vs-AfricanAmerican |
2.719700E-02 |
Caucasian-vs-Asian |
5.663800E-01 |
AfricanAmerican-vs-Asian |
1.522190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.12630000051561E-07 |
Normal-vs-Female |
2.18259999995585E-06 |
Male-vs-Female |
9.064800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.366300E-02 |
Normal-vs-Age(41-60Yrs) |
9.34110000017085E-07 |
Normal-vs-Age(61-80Yrs) |
8.18409999769898E-08 |
Normal-vs-Age(81-100Yrs) |
6.201800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.618000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.196000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.668200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.147200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.444500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.574100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.636200E-03 |
Normal-vs-Grade 2 |
5.10090000238606E-08 |
Normal-vs-Grade 3 |
6.06939999999723E-05 |
Normal-vs-Grade 4 |
3.630000E-04 |
Grade 1-vs-Grade 2 |
8.541800E-01 |
Grade 1-vs-Grade 3 |
5.580600E-01 |
Grade 1-vs-Grade 4 |
8.646000E-01 |
Grade 2-vs-Grade 3 |
1.988850E-01 |
Grade 2-vs-Grade 4 |
5.988000E-01 |
Grade 3-vs-Grade 4 |
2.326600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.99300000339286E-08 |
Normal-vs-ccB subtype |
2.775000E-04 |
ccA subtype-vs-ccB subtype |
1.712440E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.9133000000181E-06 |
Normal-vs-N1 |
4.146300E-02 |
N0-vs-N1 |
5.479200E-01 |
|
|